Complementary antibody lineages achieve neutralization breadth in an HIV-1 infected elite neutralizer is a research paper published in PLoS Pathogens (2022). On theSindex it has a DataRank of 0.249. It has been cited 4 times, with 3 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.241
From this paper's citation signal
Citation Network Contribution
7.75 × 10⁻³
From 1 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 3 citers.
HIV Vaccine Research and Design
Grant: P01 AI110657
HIV Vaccine Research and Design
Grant: P01 Al110657
Bill and Melinda Gates Foundation CAVD
Grant: OPP1132237
Bill and Melinda Gates Foundation CAVD
Grant: INV002022
Bill and Melinda Gates Foundation CAVD
Grant: OPP1146996
Bill and Melinda Gates Foundation CAVD
Grant: OPP002916
NIH/NIAID
Grant: HHSN272201800004C
the European Union’s Horizon 2020 research and innovation program
Grant: 681137
European AIDS Vaccine Initiative 2020
Netherlands Organization for Scientific Research
Grant: Vici fellowship
AMC
Grant: Ph.D. Scholarship
NIAID NIH HHS
Grant: UM1 AI144462
NIGMS NIH HHS
Grant: P41 GM103393
National Institutes of Health
Grant: 8P41GM103393-33
A Synchroton Radiation Structural Biology Resource
National Institutes of Health
Grant: 2P01AI110657-06
Cleaved, stabilized HIV-1 Env trimers for structural and vaccine studies
FWCI
0.22
Citation Percentile
0.5%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals